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Abstract
Background: Although there have been substantial medical advances that improve the outcomes following
cardiac ischemic events, gender differences in the treatment and course of recovery for patients with coronary
artery disease (CAD) continue to exist. There is a general paucity of data comparing the health related quality of
life (HRQOL) in men and women undergoing treatment for CAD. The purpose of this study was to compare
HRQOL outcomes of men and women in Alberta, at one-year following initial catheterization, after adjustment
for known demographic, co-morbid, and disease severity predictors of outcome.
Method: The HRQOL outcome data were collected by means of a self-reported questionnaire mailed to patients
on or near the one-year anniversary of their initial cardiac catheterization. Using the Seattle Angina Questionnaire
(SAQ), 5 dimensions of HRQOL were measured: exertional capacity, anginal stability, anginal frequency, quality
of life and treatment satisfaction. Data from the APPROACH registry were used to risk-adjust the SAQ scale
scores. Two analytical strategies were used including general least squares linear modeling, and proportional odds
modeling sometimes referred to as the "ordinal logistic modeling".
Results: 3392 (78.1%) patients responded to the follow-up survey. The adjusted proportional odds ratios for
men relative to women (PORs > 1 = better) indicated that men reported significantly better HRQOL on all 5
SAQ dimensions as compared to women. (PORs: Exertional Capacity 3.38 (2.75–4.15), Anginal Stability 1.23
(1.03–1.47), Anginal Frequency 1.70 (1.43–2.01), Treatment Satisfaction 1.27 (1.07–1.50), and QOL 1.74 (1.48–
2.04).
Conclusions: Women with CAD consistently reported worse HRQOL at one year follow-up compared to men.
These findings underline the fact that conclusions based on research performed on men with CAD may not be
valid for women and that more gender-related research is needed. Future studies are needed to further examine
gender differences in psychosocial adjustment following treatment for CAD, as adjustment for traditional clinical
variables fails to explain sex differences in health related quality of life outcomes.
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Introduction
Coronary artery disease (CAD) is the leading cause of
death and disability for both women and men in Canada
[1], and although there have been substantial medical
advances that improve survival for cardiac ischemic
events, gender differences in the pathophysiology, treat-
ment, course of recovery and outcomes for patients with
CAD continue to exist [1-6]. For example, it has been
reported that women with CAD are older, have a higher
burden of co-morbid illnesses [7], are more often wid-
owed, more likely to live alone, have more depressive
symptoms, have poorer psychosocial adjustment follow-
ing a CAD event [3,8,9] and lower referral/participation in
cardiac rehabilitation programs compared to men [10].
Further, there is growing evidence that suggests CAD
presents differently in women and men [11], which in
turn contributes to gender differences in the delivery of
care [7]. The differences between men and women with
CAD have great relevance particularly when addressing
secondary prevention programs. If these programs are to
be successful, it is not only crucial to carry out comprehen-
sive follow-up, but to recognize that men and women
may require different approaches to achieve maximal ben-
efit from treatment for CAD.
There is a general paucity of data comparing men and
women with CAD for differences with respect to health-
related quality of life (HRQOL) outcomes. Although
researchers have explored the association between gender,
heart disease and HRQOL, the results are contradictory
depending on the subset of patients studied and the defi-
nitions used for HRQOL. To our knowledge, no studies
have explored the association between gender, CAD and
HRQOL outcomes, using a comprehensive sample of
patients with single or multi-vessel CAD and a disease spe-
cific HRQOL measure. The sex of patients with CAD has
been reported to be associated with factors such as demo-
graphic, co-morbid illnesses, and clinical presentation
[2,12-21]. Women with CAD are older, have a higher bur-
den of co-morbid illnesses [7], and have poorer psychoso-
cial adjustment following a CAD event [3,8,9]. We
therefore hypothesized that following statistical adjust-
ment women would also experience worse HRQOL out-
comes compared to men. Therefore, the purpose of this
study was to compare the HRQOL outcomes of men and
women in Alberta with CAD at or near one-year following
initial catheterization, after adjustment for known demo-
graphic, co-morbid, and disease severity predictors of
outcome.
Methods
Selection of patient population
Eligible subjects included all adult Alberta residents over
the age of 18 years, undergoing their first cardiac catheter-
ization with 2 or more coronary arteries having ≥50%
occlusion (Duke Coronary Index between 3 and 13 [22])
registered in the Alberta Provincial Project for Outcome
Assessment in Coronary Heart Disease (APPROACH©)
database. Patients were excluded if they did not consent to
become part of the APPROACH follow-up cohort.
APPROACH is a province-wide inception cohort of all
adult Alberta residents undergoing cardiac catheterization
for ischemic heart disease. The APPROACH project was
initiated to study provincial outcomes of care and to facil-
itate quality assurance/quality improvement for patients
with CAD in Alberta [23]. The APPROACH database con-
tains detailed clinical and treatment information for adult
patients with known or suspected CAD. The data provide
a unique opportunity to study outcomes in an unselected
patient population.
Collection of clinical data
Data collection sheets were completed at the time of cath-
eterization by the referring cardiologists and were entered
by cardiac catheterization laboratory staff into on-site
computers, linked via Ethernet to a server located at the
University of Alberta. Data collected at catheterization
includes; sociodemographic characteristics (sex, age, resi-
dence address and postal code), presence or absence of co-
morbidities (renal insufficiency, hypertension, hyperlipi-
demia, diabetes mellitus, peripheral vascular disease, cer-
ebrovascular disease, smoking status, pulmonary disease,
liver/gastrointestinal disease, malignancy), disease spe-
cific variables (congestive heart failure, prior myocardial
infarction, prior thrombolytic therapy, and coronary ang-
iography results including coronary anatomy, extent of
coronary stenosis, left ventricular ejection fraction). A
treatment modality grouping was identified as the first
treatment the patient received following the initial cardiac
catheterization. Subsequent revascularization procedures
were also collected in the APPROACH database.
Collection of HRQOL data
The HRQOL outcome data were collected by means of a
self-reported questionnaire mailed to patients on or near
the one and three year anniversary of their initial cardiac
catheterization. Consent to follow-up was acquired at the
time of catheterization and ethical committees at each of
the participating hospitals approved the study. The self-
administered questionnaire included the Seattle Angina
Questionnaire (SAQ). The SAQ is a 19 item self-adminis-
tered questionnaire. Five dimensions of CAD are meas-
ured: exertional capacity (functional status), anginal
stability, anginal frequency, quality of life, and treatment
satisfaction, generating five independent scales. Each
question is measured on an ordinal scale with 1 indicating
the lowest/poorest response. Based on the results of valid-
ity, responsiveness and reliability testing, the SAQ has
been judged to be a valid, responsive and reliable instru-
ment [24]. Specifically, it has been suggested that the SAQHealth and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/21
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is sensitive to clinical changes in patient's CAD, and that
it focuses on symptoms and impairments in health that
are unique to coronary disease [24]. The Medical Out-
comes Trust has adopted the SAQ as a HRQOL measure
for patients with CAD. Furthermore, the SAQ has been
translated into 16 languages for use in Europe, the Middle
East and North America [25], and is in widespread use
worldwide. Notification of patient death occurred either
through the family by return mail or through a bi-annual
merge with data from the Alberta Bureau of Vital Statistics.
Participants were provided with two options for complet-
ing the follow-up questionnaire. They could complete the
questionnaire and mail it back in a stamped addressed
envelope or they could telephone a toll free line and
respond to a verbally administered questionnaire, which
was recorded and transcribed daily. A second question-
naire was sent to non-responders 13 months post-cathe-
terization with the same options for completion. In the
case of a questionnaire being returned due to an incorrect
address, letters were sent to the referring cardiologist to
obtain current/correct mailing addresses and question-
naires were resent. Finally, at 15 months post-catheteriza-
tion, a third reminder was sent to non-responders.
Statistical analysis
Baseline clinical and demographic characteristics of
patients who completed the questionnaire (responders)
and those with surveys that remained outstanding (non-
responders) were compared using chi-square analysis for
the categorical variables and students t-test for continuous
variables. Baseline clinical, demographic and co-morbid
characteristics of women and men were compared using
chi-square analysis for the categorical variables and stu-
dents t-test for continuous variables.
Scoring the SAQ
The SAQ is scored by assigning each response an ordinal
value, beginning with 1 for the response that implies the
lowest level of functioning, and summing across items
within each of the five dimensional scales. As suggested by
the developers, scale scores are then transformed to a 0 to
100 range by subtracting the lowest possible score, divid-
ing by the range of the scale and multiplying by 100. [24]
These scores were used as outcome variables for linear
regression modeling. Additionally, as the distributions of
the SAQ dimensional scores were graphically non-nor-
mal, we wished to have the option of analyzing the data
using non-parametric statistics. Consequently, the origi-
nal scores from each of the 5 scale scores were also added
together and divided by the number of questions that
made up the scale to create a mean dimensional score for
each respondent. To maintain the ordinal nature of the
data, frequencies of the scores were run for each of the 5
scales and categories were created based on quintiles.
Risk adjusting the SAQ scores
An analysis done comparing 4 regression models to ana-
lyze SAQ dimensional scores [26] led us to conclude that
a combination of the results derived from a least squares
linear regression model and an ordinal regression model
(risk adjusted SAQ scores and proportional odds ratios)
produced the most comprehensive interpretation of the
data from a quantitative as well as qualitative perspective.
Therefore, two strategies were used to risk adjust the SAQ
scores. The first strategy was to use general least squares
linear modeling (GLM) relying on the central-limit theo-
rem (i.e., where one has a large dataset with a large
number of cases, statistical inferences can be made based
on the approximate normality of the regression estimates
even when raw data and residuals are non-normal). The
second strategy was to use the proportional odds model
sometimes referred to as the "ordinal logistic model" [27].
Maximum likelihood estimates were used to estimate
summary odds ratios while least square means were used
to estimate risk adjusted mean SAQ scores. The regression
coefficients for the covariates in the GLM models were
multiplied by the individual covariate values and then
summed, thereby producing risk adjusted scores. Mean-
while, the beta coefficients derived from the covariates in
the ordinal regression models yield probabilities that are
converted into proportional odds ratios (PORs). Ten
regression models were constructed (5 models using ordi-
nal regression and 5 models using GLM) with separate
models for each SAQ dimensional scale for both the one-
year and the three year questionnaires. All demographic,
co-morbid and clinical variables were included and
entered at the same time into the regression models. All
statistical analyses were conducted using SPSS version
11.5.
Results
A total of 10,108 consenting patients who underwent car-
diac catheterization between January 1996 and December
1998 in the province of Alberta were sent one-year follow-
up surveys. Of these, 4,344 patients were eligible for this
study among whom 3392 (78.1%) patients responded to
the follow-up survey while 952 (21.9%) surveys remained
outstanding. Among responders, 3243 surveys were
returned completed and 149 surveys were returned
notifying the investigators that the patient had died prior
to completion of the survey.
An analysis of the differences in the baseline demographic
data and clinical characteristics of responders and non-
responders demonstrated a few significant differences
(Table 1). Compared with responders, non-responders
tended to be younger, were more likely to have diabetes
mellitus (p < 0.001) and a lower ejection fraction (p =
0.001). As well, non-responders were more likely to have
been treated with medical therapy during the first yearHealth and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/21
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following their index catheterization (35.1% versus
26.7% p < 0.001).
The mean age of the responders at the time of the index
catheterization was 64.6 years and the median age was
65.7 years. Seventy-eight percent of the sample were men.
Baseline demographic and clinical characteristics of the
analytic cohort grouped by sex are described in Table 2.
Women were significantly older (mean age: women =
66.7 years, men = 63.9 years p < 0.001), and this differ-
ence was most pronounced in the oldest age quintile
(women > 72 years 35.1%, men > 72 years 21.9%). Com-
pared to men, women were more likely to have congestive
heart failure (p = 0.001), hypertension (p < 0.001) and
diabetes mellitus (p < 0.001). Women were also more
likely to have 2 vessel disease, although the same percent-
age of women and men had left main disease. Finally,
women were more likely to have an ejection fraction
>50%, have unstable angina as the indication for
catheterization, and to be treated medically or with percu-
taneous coronary intervention.
Proportional odds ratios for men relative to women, risk
adjusted for all independent variables in the 5 models, are
presented in Figure 1. When comparing two groups, PORs
> 1.00 indicate better HRQOL scores. Overall, the risk
adjusted proportional odds ratios, adjusted for demo-
graphic and clinical characteristics, indicated that men
had significantly higher scores (better HRQOL) on all 5
SAQ dimensions as compared to women.
Risk-adjusted mean SAQ scores (scored on a scale from 0
to 100) for men and women at 1 year follow-up are pre-
s e n t e d  i n  F i g u r e  2 .  A t  o n e - y e a r  f o l l o w - u p ,  d i f f e r e n c e s
between risk-adjusted mean SAQ scores of men compared
to women were statistically significant (P ≤ 0.001). Simi-
lar to the ordinal regression analysis, men reported signif-
icantly higher scores in all 5 SAQ dimensions compared to
Table 1: Clinical Characteristics of Responders and Non-Responders
Variables Responders (N = 3243) Non-responders (N = 952) P value
Sex (% Female) 22.2% 20.7% 0.322
Age Category (% per Quintile)
30–57 years 25.0% 36.3%
58–65 years 25.0% 24.8%
66–75 years 25.0% 20.6% <0.001
>75 years 25.0% 18.3%
Pulmonary disease 6.9% 6.3% 0.514
Cerebrovascular Disease 4.8% 5.9% 0.198
Renal Disease 1.7% 1.6% 0.849
Congestive Heart Failure 10.5% 11.4% 0.413
Dialysis 1.0% 0.90 0.844
Hypertension 53.6% 56.8% 0.081
Hyperlipidemia 47.9% 46.5% 0.442
Liver/Gastrointestinal Disease 2.9% 3.6% 0.313
Malignancy 3.3% 2.2% 0.085
Prior Myocardial Infarction 43.2% 45.9% 0.144
Peripheral Vascular Disease 7.5% 8.2% 0.495
Diabetes Mellitus 18.0% 23.7% <0.001
Left Ventricular Ejection Fraction
>50% 58.0% 59.1%
<30% 4.4% 6.6%
30–50% 24.6% 25.1% 0.001
V-gramc not done due to instability 2.7% 2.4%
Missing 10.3% 6.7%
Coronary Anatomy
2 Vessel Disease 37.1% 39.1%
3 Vessel Disease 50.0% 50.0% 0.124
Left Main Disease 12.9% 10.5%
Treatment within 1st year following Index catheterization
Medical Management 26.7% 35.1%
CABG a 38.6% 32.6% <0.001
PCI with/without stent b 34.7% 32.4%
a. Coronary artery bypass graft surgery b. Percutaneous coronary intervention with/without stent c. VentriculogramHealth and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/21
Page 5 of 11
(page number not for citation purposes)
women at the one-year follow-up and the differences
between men and women were still present at the three-
year follow-up. Pairwise comparisons of men and
women's one-year follow-up risk adjusted SAQ scores are
presented in Table 3. Spertus et al have indicated that a
clinically significant difference in SAQ dimensional scores
is between 5 and 8 points [28]. Accordingly, there is a clin-
ically significant difference between men and women's one-
year functional status as measured by the exertional capac-
ity scale (mean difference 14.49 points). The differences
between men and women in the anginal frequency scale
(mean difference 6.73 points) and quality of life scale
(mean difference 7.46 points) also surpass this threshold
for clinical significance. GML coefficients for the five
models of the SAQ are presented in Table 4.
Discussion
It has been well recognized that important differences
exist between women and men with regard to the function
and progression of diseases of the cardiovascular system.
[29] Further it has been suggested that for optimal
treatment of CAD it is necessary to recognize gender
differences and their impact on the outcomes of care [30].
The results of this study indicate that women have worse
HRQOL than men one year after cardiac catheterization.
Similar to published reports [7-9], the women in our
Table 2: Difference in Demographic Data and Co-morbidities Between Men and Women
Variables Men (N = 2523) Women (N = 720) P value
Age Category (% per Quintile)
18–52 years 13.2% 11.1%
53–59 years 19.4% 14.2%
60–65 years 22.3% 16.0% <0.001
66–72 years 23.2% 18.3%
>72 years 21.9% 35.1%
Pulmonary disease 6.9% 7.1% 0.833
Cerebrovascular Disease 4.3% 6.7% 0.010
Renal Disease
Creatinine >200 mg. 1.0% 0.8%
Creatinine >200 mg./Dialysis 1.0% 1.3% 0.749
Congestive Heart Failure 9.6% 13.8% 0.001
Hypertension 51.1% 62.6% <0.001
Hyperlipidemia 47.7% 48.8% 0.626
Liver/Gastrointestinal Disease 2.7% 3.9% 0.083
Malignancy 3.3% 3.3% 0.954
Prior Myocardial Infarction 43.7% 41.5% 0.295
Peripheral Vascular Disease 7.4% 7.9% 0.651
Diabetes Mellitus 16.8% 22.2% 0.001
Left Ventricular Ejection Fraction
>50% 56.6% 63.1%
<30% 4.6% 3.5%
30–50% 25.9% 20.0% 0.003
V-gram not done due to instability 2.9% 2.1%
Missing 10.0% 11.4%
Coronary Anatomy
2 Vessel Disease 34.6% 43.3%
3 Vessel Disease 51.2% 41.9% <0.001
Left Main Disease 12.7% 12.5%
Missing 1.5% 2.2%
Treatment within 1st year following Index catheterization
Medical Management 25.5% 30.8%
CABG 40.5% 31.8% <0.001
PCI with Stent 24.0% 26.3%
PCI without Stent 9.9% 11.1%
Indication for catheterization
Stable Angina 40.8% 33.9%
Myocardial Infarction 23.1% 23.8% <0.001
Unstable Angina 27.4% 34.4%
Other 8.6% 9.9%Health and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/21
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study were significantly older, and more likely to have
more co-morbid illnesses compared to men. At the same
time the women were more likely to be treated medically
or with PCI whereas the men were more likely to be
treated with CABG. Although some studies have suggested
that women have less access to care or have poorer out-
comes, consistent findings are still unavailable [31-34].
Despite these crude differences in co-morbid illnesses,
ejection fraction and treatment modality, after risk adjust-
ing the SAQ dimensional scores for all demographic, clin-
ical, co-morbid and treatment variables, gender remained
independently associated with HRQOL outcomes with
women reporting worse HRQOL outcomes compared to
men.
Quality of life outcomes at one-year follow-up Figure 1
Quality of life outcomes at one-year follow-upHealth and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/21
Page 7 of 11
(page number not for citation purposes)
Mean adjusted Seattle Angina Questionnaire dimensions by gender at one-year follow-up Figure 2
Mean adjusted Seattle Angina Questionnaire dimensions by gender at one-year follow-up
Table 3: Risk-Adjusted Mean SAQ Scores by Sex.
Variable Exertional Capacity Anginal Stability Anginal Frequency Treatment Satisfaction Quality of life
Treatment Mean Score 95% lower and 
upper Cl
Mean Score 95% lower and 
upper Cl
Mean Score 95% lower and 
upper Cl
Mean Score 95% lower 
and upper Cl
Mean Score 95% lower 
and upper Cl
Men 75.92 74.9–76.9 81.76 80.7–82.8 88.79 88.0–89.6 88.59 87.9–89.3 77.36 76.5–78.2
Women 61.43 59.4–63.5 77.98 75.9–80.0 82.06 80.5–83.6 86.39 85.1–87.7 69.90 68.2–71.6
Mean 
Difference
14.49 p < 001 3.79 p = 0.001 6.73 p < 0.001 2.19 p = 0.005 7.46 p < 0.001
The mean SAQ scores are risk adjusted for sex, age, renal insufficiency, hypertension, hyperlipidemia, diabetes mellitus, peripheral vascular disease, 
cerebrovascular disease, pulmonary disease, liver/gastrointestinal disease, malignancy, congestive heart failure, prior myocardial infarction, prior 
thrombolytic therapy, coronary anatomy, extent of coronary stenosis, and left ventricular ejection fraction.Health and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/21
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The literature on gender differences in HRQOL for
patients with CAD is sparse and somewhat contradictory.
Three studies examined gender differences in HRQOL fol-
lowing acute myocardial infarction, and these reported no
gender differences in HRQOL [13,35,36], yet found that
women reported higher levels of depression and less
social support [13], were at increased risk of death and
long length of stay in subsequent hospitalizations [36],
and less likely to undergo rehabilitation if diagnosed as
hypertensive [35]. In contrast, two studies [37,38]
reported that women reported worse HRQOL following
acute myocardial infarction compared to men as meas-
ured by elevated levels of anxiety, depression, poorer gen-
eral health [37] and overall worse psychosocial profiles
[38]. One study investigated the HRQOL of patients with
stable angina on a waiting list for coronary revasculariza-
tion, and reported that women had higher frequencies of
chest pain, dyspnea and more sleep disorders [39]. King
and colleagues [40] used the McMaster Health State Pro-
file to examine the effect of gender on short-term recovery
from cardiac surgery and found that although the women
in the study were more functionally limited and reported
lower life satisfaction and social support pre-operatively
compared to men, there were in fact few significant differ-
ences between men and women 3 months postoperatively
aside from persistently lower social support. Finally, two
studies that examined the gender differences in HRQOL
of patients with heart failure [41,42] reported that women
had worse HRQOL ratings than men particularly for phys-
ical health status and activities of daily living. Based on
the conflicting nature of these studies, one might specu-
late that higher levels of depression [13,15,16] and less
Table 4: General Linear Model Coefficients










Intercept 95.28 59.27 73.21 69.89 41.60
Sex Male (1) 14.49 3.79 6.74 2.19 7.46






Pulmonary disease (0/1)* -6.83 -3.99 -2.78 -0.25 -3.78
Cerebrovascular Disease (0/1) -5.11 -2.85 -1.81 -1.50 -1.59
Renal Disease (0/1) -4.56 4.86 2.28 0.27 4.61
Congestive Heart Failure (0/1) -7.41 -0.31 0.52 0.49 -1.58
Hypertension (0/1) -0.40 -0.05 -0.31 -0.34 0.15
Hyperlipidemia (0/1) 2.12 -0.57 1.01 0.92 1.32
Liver/Gastrointestinal Disease (0/1) 0.24 0.32 0.85 0.02 0.19
Malignancy (0/1) 1.32 -1.80 0.68 0.11 0.07
Prior Myocardial Infarction (0/1) -2.05 0.19 0.32 0.75 0.56
Peripheral Vascular Disease (0/1) -6.54 4.49 -0.49 0.43 0.30
Diabetes Mellitus (0/1) -5.87 -1.78 -2.92 -0.53 -2.51




V-gram not done due to instability (3)
Missing (4)
Coronary Anatomy -0.49 3.41 1.82 1.39 2.19
2 Vessel Disease (2)
3 Vessel Disease (3)
Left Main Disease (4)
Missing (0)
Treatment within 1st year following 
Index catheterization
3.59 4.11 3.88 2.16 3.19
Medical Management (0)
CABG (1)
PCI with/without Stent (2) 





*(0/1) 0 = absent 1 = presentHealth and Quality of Life Outcomes 2004, 2 http://www.hqlo.com/content/2/1/21
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social support [13,18] in women following a cardiac event
may have influenced their overall reported HRQOL.
The predictive value of psychosocial factors such as social
support and depression in CAD outcomes is not well
understood, regardless of gender. The influence of psy-
chosocial factors in the course and outcomes of CAD has
generated considerable interest since traditional risk fac-
tors have been unable to provide a comprehensive explan-
atory model, accounting for, at best, 50% of the variance
in morbidity and mortality outcomes. These two variables
should be included in future studies of HRQOL in
patients with CAD as they may explain some of the gender
differences in HRQOL in this population. Indeed, in our
study, adjustment for a number of measured clinical vari-
ables did not 'explain away' sex differences in HRQOL,
leaving us to speculate that variables that we did not
measure – like social support and depression – may be
contributing to sex differences in outcome.
A systematic review of the SAQ identified 62 studies that
either referenced or used the SAQ to measure HRQOL
outcomes [43]. Although the SAQ was tested and deter-
mined to be a valid, reliable, responsive instrument to
measure the HRQOL of patients with CAD [24], and has
been used in a variety of settings with a variety of samples
including men and women, the original scale was
validated on a sample of older men who were inpatients
or outpatients at a Veterans Medical Centre. Consequently
the items that make up the dimensional scores may be
gender biased. There is growing evidence to suggest that
women may experience angina differently than men.
Rather than a heavy localized chest pain that some refer to
as the typical 'Hollywood Heart Attack', women often
report more diffuse, hot, burning chest pain, jaw pain,
shoulder blade pain [44] and/or nausea [45-49]. As a
result, the items that make up the exertional capacity scale
that address the limitations in activities of daily living due
to 'chest pain, chest tightness and/or shortness of breath'
[24], may actually overestimate women's exertional capac-
ity. The results of this study indicate that women reported
greater limitations in exertional capacity compared to
men indicating that regardless of how angina is mani-
fested, the items in the exertional capacity scale appear to
be identifying limitations to functional status resulting
from CAD.
There are limitations to this study. This study is an obser-
vational study based on a clinical registry that although
quite detailed, may lack information on clinical variables
that may confound the association between gender and
quality of life. Consequently, the observed differences
between genders in HRQOL outcomes may be due to
residual confounding. Since HRQOL outcomes may be
associated with a variety of demographic and clinical
characteristics, we have attempted to adjust for baseline
differences in our analysis. A second limitation is that
HRQOL outcomes for this study were measured only at
one time point, one-year post catheterization. As such we
are not able to determine exactly when the HRQOL gen-
der differences noted in this study emerge. Further
research is required to analyze when HRQOL gender dif-
ferences begin in the natural history of coronary artery dis-
ease, and the subsequent HRQOL "trajectories" that ensue
for men and women. To that end a study is presently
underway in which we collect 'baseline' HRQL data at
one-week post catheterization.
Notwithstanding these limitations, this study is unique
on several fronts. Of primary significance is the fact that
the study covered a large geographically defined study
population that yielded a high response rate to a one-year
follow-up questionnaire. HRQOL questionnaires are par-
ticularly beneficial at enhancing the scope of outcome
measures beyond the traditional ones of disability and/or
death. By using a validated HRQOL measure (SAQ), we
were able to evaluate the HRQOL outcomes of treatment
for patients with CAD. More importantly, this study
provides the opportunity to gain knowledge, insight, and
a better understanding of the impact of CAD, and 'real
world' HRQOL outcomes of a population based cohort
with multi-vessel CAD.
Conclusion
CAD imposes a great influence on HRQOL outcomes.
Women report poorer HRQOL than do men at one year
following treatment for multi-vessel CAD. Gender differ-
ences were noted in all 5 dimensions measured by the
SAQ including exertional capacity, anginal stability, angi-
nal frequency, treatment satisfaction and quality of life.
These findings underline the fact that conclusions based
on research performed on men with CAD may not be
valid for women and that more gender-related research is
needed. Future studies are needed to further examine gen-
der differences in psychosocial adjustment following
treatment for CAD, as adjustment for traditional clinical
variables fails to explain sex differences in quality of life
outcomes.
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